Musings From the Power List: Jason Bock
Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development
False
Advertisement
Related Content
Industry News
Research News
Development & Clinical
BMS Details Patient Death in Zola-Cel Multiple Sclerosis Trial
November 3, 2026
2 min read
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
Drug Discovery
Development & Clinical
Regulation & Standards
America Votes, China Plans
November 3, 2026
23 min read
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
Development & Clinical
Biopharma
Can Immunopeptidomics Redefine Cancer Immunotherapy Development?
November 3, 2026
3 min read
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
Formulation
Small Molecules
Development & Clinical
Strategic Development of Complex Oral Therapies
November 2, 2026
5 min read
Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies